interstitial cystitis
Information
- Disease name
- interstitial cystitis
- Disease ID
- DOID:13949
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT05414305 | Active, not recruiting | Phase 2 | The Female Microbiome in Patients Undergoing Bladder Instillation Therapy | October 1, 2020 | December 2023 |
NCT05485207 | Active, not recruiting | Early Phase 1 | Transvaginal Botulinum Toxin A for Interstitial Cystitis / Bladder Pain Syndrome | April 4, 2022 | February 28, 2025 |
NCT00004316 | Completed | Phase 1/Phase 2 | Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis | June 1995 | |
NCT00124306 | Completed | Phase 3 | Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS) | February 2005 | December 2008 |
NCT00150488 | Completed | N/A | URACYST® For the Treatment of GAG Deficient Interstitial Cystitis | September 2005 | February 2008 |
NCT00194610 | Completed | Phase 4 | Botox as a Treatment for Interstitial Cystitis in Women | May 2004 | September 2010 |
NCT00237081 | Completed | Genetics of Interstitial Cystitis | June 2004 | November 2008 | |
NCT06209008 | Completed | Phase 3 | Submucosal Intravesical Injection of Platelet-rich Plasma in the Treatment of Painful Bladder Syndrome | April 1, 2021 | December 1, 2023 |
NCT00256542 | Completed | Phase 2 | Study of U101 for Bladder Pain and/or Urgency | January 2006 | September 2006 |
NCT00295854 | Completed | Phase 2 | Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis | May 2005 | October 2006 |
NCT00376298 | Completed | Urology Database to Evaluate Clinical Information and Improve Patient Care. | February 2004 | December 2015 | |
NCT00379002 | Completed | The Women's Urology Center/WISH Database Project | July 2006 | January 2015 | |
NCT03463499 | Completed | N/A | The Efficacy and Safety of Intravesical Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients | September 22, 2017 | December 31, 2021 |
NCT00056251 | Completed | Phase 2 | Interstitial Cystitis | January 2003 | August 2003 |
NCT03103477 | Completed | Platelet Activating Factor Stability in Urine | January 27, 2017 | February 28, 2017 | |
NCT03282318 | Completed | Phase 2 | A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis | September 28, 2017 | March 21, 2019 |
NCT00420550 | Completed | Phase 2 | Study of Biomarkers and the Relaxation Response Using Guided Imagery in Women With IC | January 2007 | December 2007 |
NCT00434343 | Completed | N/A | Physical Therapy Trial for Pelvic Pain | November 2006 | November 2007 |
NCT05223244 | Completed | Phase 4 | Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC | October 1, 2011 | March 30, 2020 |
NCT00517868 | Completed | Phase 2 | Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis | August 2007 | April 2008 |
NCT00527917 | Completed | Phase 2 | A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome. | September 2007 | September 2008 |
NCT00546858 | Completed | Relationship of Interstitial Cystitis to Vulvodynia | October 2007 | May 2009 | |
NCT00554320 | Completed | N/A | Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain | January 2009 | June 2009 |
NCT00590473 | Completed | N/A | Sacral Neuromodulation in Patients With IC | April 2007 | February 2009 |
NCT00704457 | Completed | Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC) | February 2004 | December 2007 | |
NCT00733603 | Completed | N/A | Physical Therapy in Women With Interstitial Cystitis | June 2008 | December 2009 |
NCT00739739 | Completed | Phase 2 | An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis | August 2008 | January 2010 |
NCT00810329 | Completed | Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome | July 2007 | April 2011 | |
NCT00817388 | Completed | Correlating Ic/Pbs Symptoms With Urine Biomarkers | January 2009 | May 2010 | |
NCT05179460 | Completed | A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopathy | October 26, 2021 | May 20, 2022 | |
NCT00873171 | Completed | Osteopathic Manipulation Therapy in the Treatment of Interstitial Cystitis | January 2009 | November 2009 | |
NCT00903435 | Completed | Quantitative Studies of Urinary Bladder Sensation | May 2007 | November 2009 | |
NCT00919113 | Completed | Phase 2 | Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome | July 2009 | December 2010 |
NCT00919802 | Completed | Phase 4 | Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis | June 2010 | September 2015 |
NCT00971568 | Completed | Urinary Biomarkers Characteristic to Interstitial Cystitis | September 2009 | September 2011 | |
NCT04824820 | Completed | N/A | Improving Female Sexual Wellness | April 10, 2021 | April 5, 2023 |
NCT01083979 | Completed | N/A | Intravesical Liposomes for Ulcerative Cystitis | August 2010 | October 2010 |
NCT01098279 | Completed | Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis | December 2009 | June 2014 | |
NCT01138800 | Completed | Assessing Chronic Pain Conditions in Patients (Pts) With and Without (w&wo) Interstitial Cystitis | May 2010 | March 2012 | |
NCT01150565 | Completed | Phase 1 | Safety Study of LiRIS in Interstitial Cystitis (IC) Patients | July 2010 | September 2011 |
NCT01195116 | Completed | Phase 4 | Usefulness of Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis | May 2010 | April 2012 |
NCT01197261 | Completed | Phase 2 | OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS) | September 2010 | June 2013 |
NCT04821882 | Completed | N/A | Intravesical Injection of Dextrose to Improve Lower Urinary Tract Symptoms Caused by Chronic Cystitis | May 1, 2019 | October 11, 2020 |
NCT04820855 | Completed | N/A | Mindfulness and Yoga for Pain With Interstitial Cystitis Evaluation | May 18, 2021 | December 31, 2023 |
NCT01294878 | Completed | Phase 3 | Omalizumab in Interstitial Cystitis/Bladder Pain Syndrome | March 2009 | October 2010 |
NCT01295814 | Completed | Phase 3 | Efficacy Study of Adalimumab to Treat Interstitial Cystitis | March 2011 | July 2013 |
NCT04540887 | Completed | N/A | PEMF Therapy to Treat Interstitial Cystitis/Bladder Pain Syndrome | February 24, 2021 | November 30, 2021 |
NCT04401176 | Completed | Phase 2 | Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome | September 15, 2020 | June 1, 2023 |
NCT04313972 | Completed | Phase 4 | IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone | September 7, 2021 | February 23, 2023 |
NCT04275297 | Completed | N/A | Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome | July 13, 2020 | June 16, 2023 |
NCT01393223 | Completed | Phase 2 | Evaluation of Intravesical LP08 in Patients With Interstitial Cystitis/Painful Bladder Syndrome | July 21, 2015 | June 14, 2018 |
NCT04208087 | Completed | Phase 1/Phase 2 | PK and Safety of SI-722 in IC/BPS | March 30, 2020 | January 12, 2021 |
NCT04010513 | Completed | N/A | Hypnosis for Bladder Pain Syndrome | October 3, 2019 | August 15, 2020 |
NCT01479725 | Completed | Phase 2 | Prospective Trial Comparing Response to Hyperbaric Oxygen Treatment in Patients With Interstitial Cystitis | March 2011 | May 2013 |
NCT01559961 | Completed | Phase 1 | Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome | March 2012 | June 2013 |
NCT03987594 | Completed | N/A | Comparing the Effect of Fulguration Versus Fulguration and Hydrodistension in Interstitial Cystitis/Bladder Pain Syndrome | August 1, 2015 | October 31, 2018 |
NCT01731470 | Completed | N/A | Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) | July 2012 | August 2013 |
NCT01738464 | Completed | Microbiomes of Pelvic Pain | June 2012 | July 8, 2023 | |
NCT03931538 | Completed | N/A | Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study | July 17, 2018 | October 1, 2019 |
NCT03844581 | Completed | N/A | Effect of Interferential Electrical Stimulation on Pain Perception and Disability Level on Interstitial Cystitis | January 1, 2019 | February 13, 2019 |
NCT03844412 | Completed | Phase 2 | Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments | November 4, 2019 | May 30, 2024 |
NCT01882543 | Completed | Phase 2 | Efficacy and Safety of AQX-1125 in IC/BPS | June 2013 | June 2015 |
NCT01969773 | Completed | Phase 2 | Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment | December 2012 | December 2014 |
NCT01985880 | Completed | The Efficacy of Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome | November 19, 2013 | May 12, 2016 | |
NCT01990898 | Completed | Phase 2 | Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action | November 2013 | April 2016 |
NCT01997983 | Completed | Phase 1/Phase 2 | Efficacy and Safety of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in IC Patients | November 2013 | August 2015 |
NCT02000401 | Completed | Phase 4 | Intranasal Ketorolac Tromethamine (Sprix) for Acute Pain of Interstitial Cystitis Flare of Pain | May 2012 | July 2013 |
NCT02150811 | Completed | Observational Study of Hunner's Ulcer in Patient With Interstitial Cystitis/Bladder Pain Syndrome | June 2, 2016 | January 31, 2017 | |
NCT02232282 | Completed | N/A | Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial | October 2014 | August 16, 2017 |
NCT02247557 | Completed | Phase 2 | Intravesical Instillation of Liposome Encapsulated Botulinum Toxin A (Lipotoxin) in Treatment of Interstitial Cystitis | September 2014 | February 2017 |
NCT02297100 | Completed | Phase 4 | Intravesicular Onabotulinumtoxin A in Interstitial Cystitis | December 2014 | January 10, 2018 |
NCT02457182 | Completed | N/A | Mindfulness-Based Therapy for Interstitial Cystitis/Bladder Pain Syndrome | November 2014 | June 2015 |
NCT02514265 | Completed | Trans-MAPP Symptom Patterns Study (SPS) | July 1, 2015 | June 2020 | |
NCT03755375 | Completed | N/A | Physiotherapeutic Interventions Applied to the Bladder Pain Syndrome | February 5, 2018 | December 19, 2019 |
NCT03722992 | Completed | N/A | The Effects of Mindfulness-based Stress Reduction in Interstitial Cystitis Patients | March 7, 2019 | March 15, 2020 |
NCT02550561 | Completed | N/A | Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of IC/PBS | June 2015 | March 2018 |
NCT03693001 | Completed | N/A | HBOT for Patients With IC/FM (Interstitial Cystitis/Fibromyalgia) | June 1, 2016 | June 15, 2018 |
NCT03619486 | Completed | N/A | Low Energy Shock Wave for the Treatment of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) | July 4, 2018 | June 30, 2020 |
NCT02898220 | Completed | Trans-MAPP II Study of Urologic Chronic Pelvin Pain | September 2016 | June 2022 | |
NCT03003845 | Completed | S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain | February 26, 2019 | February 27, 2020 | |
NCT03023241 | Completed | N/A | Diagnosis of Bladder Pain Syndrome / Interstitial Cystitis | December 2004 | July 2021 |
NCT03024619 | Completed | Interstitial Cystitis and Urinary pH | February 2016 | June 4, 2019 | |
NCT03463915 | Completed | Phase 3 | Clinical Trial Comparing Two Bladder Instillations for IC/BPS | January 25, 2019 | October 23, 2020 |
NCT03041194 | Completed | Dietary Impact on Urinary pH in Women With Interstitial Cystitis | January 2015 | December 2015 | |
NCT05456308 | Enrolling by invitation | N/A | What is the Optimal Technique for Hydrodistention? | July 1, 2022 | October 2024 |
NCT06212661 | Enrolling by invitation | Migraine Medication Effects on Urinary Symptoms | April 5, 2024 | May 2026 | |
NCT06394830 | Not yet recruiting | Phase 2 | Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS) | June 2024 | June 2025 |
NCT04734106 | Not yet recruiting | Early Phase 1 | Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis | July 2024 | October 2024 |
NCT05062902 | Not yet recruiting | Early Phase 1 | A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management | December 2024 | December 2027 |
NCT05857020 | Not yet recruiting | N/A | Auricular Acupressure Therapy for Patients With IC/BPS | July 2024 | October 2025 |
NCT05912946 | Not yet recruiting | Phase 2/Phase 3 | Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis | October 15, 2023 | October 15, 2024 |
NCT06013449 | Not yet recruiting | N/A | Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations | July 2024 | January 2025 |
NCT06096597 | Not yet recruiting | Phase 2/Phase 3 | Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome | July 2024 | June 2026 |
NCT06366269 | Not yet recruiting | N/A | Acupuncture First for IC/BPS | June 2024 | June 2026 |
NCT03468530 | Recruiting | Therapeutic Effects of Endoscopic Ablation of Hunner Lesions in Interstitial Cystitis/ Bladder Pain Syndrome Patients | August 1, 2012 | December 31, 2025 | |
NCT06299683 | Recruiting | N/A | Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment | May 1, 2024 | August 4, 2028 |
NCT05276466 | Recruiting | N/A | Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the Evaluation and Management of Females With Chronic Bladder Pain and Cystitis-like Symptoms | February 1, 2022 | December 15, 2023 |
NCT05275647 | Recruiting | Phase 2 | Efficacy and Safety of Low Energy Shock Wave Plus BotulinumToxin A in Treating Patients With Interstitial Cystitis | May 18, 2021 | September 2024 |
NCT04845217 | Recruiting | Phase 1/Phase 2 | Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome | September 15, 2021 | December 2023 |
NCT03523559 | Recruiting | Genetic and Histopathologic Characteristics of Interstitial Cystitis | March 31, 2018 | December 2024 | |
NCT05127616 | Recruiting | N/A | EPPIC: Easing Pelvic Pain Interventions Clinical Research Program | August 10, 2022 | May 31, 2026 |
NCT05147779 | Recruiting | Phase 1 | Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis | September 12, 2021 | December 2025 |
NCT05149573 | Recruiting | N/A | Investigation of PEMF Therapy for Female Patients With IC/BPS | August 29, 2022 | April 2025 |
NCT00499317 | Recruiting | Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) | January 15, 2007 | December 31, 2026 | |
NCT06232200 | Recruiting | N/A | Investigation of the Effectiveness of Acupuncture in Patients Diagnosed With Interstitial Cystitis | January 1, 2024 | January 1, 2025 |
NCT05740007 | Recruiting | Phase 2 | A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome | March 28, 2023 | November 2025 |
NCT05737121 | Recruiting | Phase 2 | Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS | May 22, 2023 | May 22, 2024 |
NCT05726786 | Recruiting | Phase 3 | The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) | April 10, 2023 | October 2026 |
NCT05699551 | Recruiting | N/A | Supervised Exercise as a Therapeutic Strategy for Interstitial Cystitis/Bladder Pain Syndrome | May 10, 2023 | September 2025 |
NCT04734847 | Recruiting | N/A | Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome | June 1, 2021 | August 15, 2025 |
NCT05658874 | Recruiting | Phase 3 | A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain | December 1, 2022 | January 1, 2025 |
NCT00389142 | Recruiting | Identifying Genetic Causes of IC/BPS | January 15, 2006 | December 31, 2026 | |
NCT04450316 | Suspended | Phase 2 | Low-dose Naltrexone for Bladder Pain Syndrome | October 8, 2020 | October 2024 |
NCT02591199 | Terminated | Phase 2 | Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome | September 2015 | June 18, 2018 |
NCT02517996 | Terminated | N/A | Use of Preemptive Pudendal Nerve Block Prior to Hydrodistention for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) | February 2015 | June 2018 |
NCT01824303 | Terminated | Phase 2 | Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis | March 2013 | December 2014 |
NCT01813565 | Terminated | N/A | The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome. | March 20, 2013 | December 1, 2016 |
NCT01678911 | Terminated | Phase 4 | Efficacy of Gralise® for Chronic Pelvic Pain | August 2012 | June 2014 |
NCT01475253 | Terminated | Phase 2 | Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis | November 2011 | December 2012 |
NCT04268810 | Terminated | Phase 4 | Prospective Trial Comparing Intravesical Chondroitin Sulphate 2% and DMSO in the Treatment of PBS/Interstitial Cystitis | March 2010 | December 31, 2013 |
NCT00086684 | Terminated | Phase 4 | Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis | September 2003 | June 2011 |
NCT01280864 | Terminated | MAPP Investigation of Pelvic Floor-Brain Neurobiologic Axis in IC/IBS and IBS | March 2010 | August 2011 | |
NCT00253006 | Terminated | Analysis of Expression of Nitric Oxide Syntheses and Their Functional Role in Human Urothelium | January 2006 | January 2008 | |
NCT00451867 | Terminated | Phase 3 | A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . . | March 2007 | April 2008 |
NCT00317070 | Terminated | Phase 2 | Trial Comparing Intravesical Cocktail With Intravesical Dimethyl Sulfoxide (DMSO) in Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC) | April 2006 | February 2009 |
NCT03480477 | Terminated | Adverse Childhood Experiences in Urogynecologic Patients | April 9, 2018 | February 1, 2019 | |
NCT02547298 | Terminated | Interstitial Cystitis (IC)-Like Findings With Hydrodistension | June 2015 | January 18, 2018 | |
NCT01069263 | Unknown status | N/A | Comparative Study Between Hyperbaric Therapy and Intravesical Dimethyl Sulfoxide Instillation for Interstitial Cystitis | February 2010 | July 2015 |
NCT05337813 | Unknown status | N/A | Effects of Low-intensity Excoporeal Shock Wave Therapy (LiESWT) on Women With Pelvic Floor Dysfunction | April 10, 2020 | March 31, 2023 |
NCT02858453 | Unknown status | Phase 3 | Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome | July 2016 | February 2020 |
NCT04610359 | Unknown status | Phase 1 | Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis | October 20, 2020 | December 2022 |
NCT01838486 | Unknown status | N/A | Bladder Thermal Distention for Patients With Interstitial Cystitis / Painful Bladder Syndrome | June 2012 | April 2014 |
NCT01301365 | Unknown status | Autonomic Response During Cystodistension in Patients Suspected of Having Interstitial Cystitis | November 2010 | June 2011 | |
NCT00094874 | Unknown status | Phase 3 | Acupuncture for the Treatment of Interstitial Cystitis (IC) Symptoms | September 2004 | September 2005 |
NCT01437579 | Unknown status | Phase 2 | Efficacy of Botulinum Toxin Type A in Patients With Bladder Pain Syndrome/Intersticial Cystitis and Hunners' Lesions | June 2011 | June 2012 |
NCT03104361 | Unknown status | Phase 1 | Platelet-Rich Plasma (PRP) Injection in Treatment of Interstitial Cystitis | April 2017 | July 2018 |
NCT04118946 | Unknown status | Phase 1/Phase 2 | Platelet Enriched Plasma for Treatment of Interstitial Cystitis | March 20, 2019 | September 2020 |
NCT05155384 | Unknown status | N/A | Biopsychosocial and Conventional Approach in Bladder Pain Syndrome | November 12, 2021 | October 15, 2022 |
NCT01255345 | Unknown status | Female Chronic Pelvic Pain | January 2011 | December 2012 | |
NCT01311479 | Unknown status | N/A | Osteopathic Manipulation for Female Interstitial Cystitis Patients With Sacroiliac Joint Dysfunction | November 2009 | October 2018 |
NCT01312259 | Unknown status | Phase 4 | Clinical Efficacy of Changing the InterStim® Parameters in Patients With Interstitial Cystitis/Painful Bladder Syndrome | April 2011 | April 2018 |
NCT04447729 | Withdrawn | Phase 2 | A Study to Test if Fremanezumab Reduces Pain in Patients With Interstitial Cystitis-Bladder Pain Syndrome | October 15, 2020 | February 10, 2022 |
NCT05226832 | Withdrawn | N/A | Intradetrusor Triamcinolone Injection in the Management of Interstitial Cystitis/Bladder Pain Syndrome | August 2022 | March 2023 |
NCT04349930 | Withdrawn | Phase 1 | The CBD-IC Randomized Controlled Trial: Evaluation of Hemp Cannabidiol SuppositoRies for Pain and Urinary SymptOms in INterstitial Cystitis (CHRONIC) | January 2021 | September 2022 |
NCT00823030 | Withdrawn | N/A | Effect of Intravesical Lidocaine on Urodynamic and Symptomatic Parameters of Interstitial Cystitis | January 2009 | January 2013 |
NCT03027076 | Withdrawn | Microbiome of Urologic Chronic Pelvic Pain Syndrome | November 2013 | January 2015 | |
NCT01378754 | Withdrawn | N/A | Evaluate The Effectiveness Of Fospropofol (Lusedra®) For Induction Of Anesthesia | June 2011 | June 2014 |
- Disase is a (Disease Ontology)
- DOID:1679
- Cross Reference ID (Disease Ontology)
- GARD:6787
- Cross Reference ID (Disease Ontology)
- MESH:D018856
- Cross Reference ID (Disease Ontology)
- NCI:C27189
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:197834003
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0282488
- Exact Synonym (Disease Ontology)
- ulcerative cystitis
- OrphaNumber from OrphaNet (Orphanet)
- 37202